IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Seattle Genetics Stock and on which exchange is it traded?
The symbol for Seattle Genetics is SGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Seattle Genetics Stock?
Seattle Genetics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Seattle Genetics Stock?
Seattle Genetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Seattle Genetics Stock.

What's the current price of Seattle Genetics Stock?
As of the end of day on the 2024-03-12, the price of an Seattle Genetics (SGEN) share was $228.74.

What is the 52-week high and low for Seattle Genetics Stock?
The 52-week high for Seattle Genetics Stock is $228.96 and the 52-week low is $184.74.

What is the market capitalization of Seattle Genetics Stock?
As of the 2024-03-12, the market capitalization of Seattle Genetics is 43.155B.

When is the next earnings date for Seattle Genetics?
The upcoming earnings date for Seattle Genetics is Apr 25, 2024.
Click to get the best stock tips daily for free!

About Seattle Genetics

Seattle Genetics Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibit... SGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT